Yuan-dong Shan
Overview
Explore the profile of Yuan-dong Shan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu W, Wang Y, Fang W, Chen J, Sha Y, Huang X, et al.
Zhonghua Nei Ke Za Zhi
. 2011 May;
50(3):205-8.
PMID: 21600082
Objective: To analyze the disease spectrum of patients admitted to the General Internal Medicine Unit at Peking Union Medical College Hospital, which is the first academic division of general internal...
2.
Zhu W, Shan Y, Guo J, Wei J, Yang X, Li T, et al.
Circ J
. 2007 May;
71(6):826-33.
PMID: 17526976
Background: The efficacy and safety of nicorandil were evaluated in Chinese patients with stable angina pectoris (AP) in a double-blind, multicenter, active-controlled, randomized clinical trial. Methods And Results: After a...
3.
Bai C, Xu G, Zhao Y, Han S, Shan Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2004 Sep;
26(4):437-41.
PMID: 15379272
Objective: To assess the efficacy and safety of recombinant human thrombopoietin (rhTPO) on chemotherapy-induced thrombocytopenia in patients with solid tumor. Methods: In this randomized crossover self-controlled multi-center clinical trial, 154...
4.
Zhao Y, Wang Q, Zhai M, Xu J, Chen X, Liu W, et al.
Zhonghua Nei Ke Za Zhi
. 2004 Sep;
43(8):608-10.
PMID: 15355668
Objective: To evaluate the efficacy and safety of human recombinant thrombopoietin (rhTPO, a product of Sunshine Pharmaceutical Co Ltd, China) in chronic refractory idiopathic thrombocytopenic purpura. Methods: Eighty-two patients with...
5.
Bai C, Zou X, Zhao Y, Han S, Shan Y
Zhonghua Yi Xue Za Zhi
. 2004 Apr;
84(5):397-400.
PMID: 15061993
Objective: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) on chemotherapy-induced severe thrombocytopenia. Methods: In this self-controlled multi-center clinical trial, 81 patients, 23 with solid tumor and...